These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17627415)

  • 1. Tumor radioimmunolocalization in nude mice by mono- and divalent- single-chain Fv antiplacental alkaline phosphatase antibodies.
    Sheikholvaezin A; Eriksson D; Ahlström KR; Johansson L; Stigbrand T
    Cancer Biother Radiopharm; 2007 Feb; 22(1):64-72. PubMed ID: 17627415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of nonlabeled, 125I-labeled, and anti-idiotypic antiplacental alkaline phosphatase monoclonal antibodies at experimental radioimmunotargeting.
    Rossi Norrlund R; Holback D; Johansson L; Hietala SO; Ahlström KR
    Acta Radiol; 1997 Nov; 38(6):1087-93. PubMed ID: 9394676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.
    Goel A; Baranowska-Kortylewicz J; Hinrichs SH; Wisecarver J; Pavlinkova G; Augustine S; Colcher D; Booth BJ; Batra SK
    J Nucl Med; 2001 Oct; 42(10):1519-27. PubMed ID: 11585867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the generation of recombinant single-chain antibodies against placental alkaline phosphatase.
    Sheikholvaezin A; Sandström P; Eriksson D; Norgren N; Riklund K; Stigbrand T
    Hybridoma (Larchmt); 2006 Aug; 25(4):181-92. PubMed ID: 16934014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential use of a monoclonal antibody to placental alkaline phosphatase (PLAP) to detect lymph node metastases of seminoma.
    Koshida K; Uchibayashi T; Yamamoto H; Yokoyama K; Hirano K
    J Urol; 1996 Jan; 155(1):337-41. PubMed ID: 7490882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour radioimmunolocalization in nude mice by use of antiplacental alkaline phosphatase monoclonal antibodies.
    Stigbrand T; Hietala SO; Johansson B; Makiya R; Riklund K; Ekelund L
    Tumour Biol; 1989; 10(5):243-51. PubMed ID: 2814233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary radioimmunoimaging and biodistribution of ¹³¹iodine-labeled single-chain antibody fragment against progastrin-releasing peptide(₃₁₋₉₈) in small cell lung cancer xenografts.
    Hong Z; Shi Y; Liu Z; Zhou X; Yang Y; Tang J
    Chin Med J (Engl); 2014; 127(11):2007-11. PubMed ID: 24890142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syngeneic anti-idiotypic antibodies eliminate excess radiolabeled idiotypes at experimental radioimmunolocalization.
    Ullén A; Riklund Ahlström K; Makiya R; Stigbrand T
    Cell Biophys; 1995 Aug; 27(1):31-45. PubMed ID: 7493397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and purification of a covalently linked divalent tandem single-chain Fv antibody against placental alkaline phosphatase.
    Sheikholvaezin A; Eriksson D; Riklund K; Stigbrand T
    Hybridoma (Larchmt); 2006 Oct; 25(5):255-63. PubMed ID: 17044780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multivalent recombinant antibody fragment specific for carcinoembryonic antigen.
    Perez L; Ayala M; Pimentel G; Bell H; Canaán-Haden L; Bequet M; González LJ; Miranda M; Ravelo R; Roque L; Acevedo B; Oliva JP; Gavilondo JV
    Biotechnol Appl Biochem; 2006 Jan; 43(Pt 1):39-48. PubMed ID: 16101587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the active site of the placental isozyme of alkaline phosphatase by phage-displayed scFv antibodies selected by a specific uncompetitive inhibitor.
    Saini D; Kala M; Jain V; Sinha S
    BMC Biotechnol; 2005 Dec; 5():33. PubMed ID: 16372914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.
    Wittel UA; Jain M; Goel A; Chauhan SC; Colcher D; Batra SK
    Nucl Med Biol; 2005 Feb; 32(2):157-64. PubMed ID: 15721761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour and cellular localization by use of monoclonal and polyclonal antibodies to placental alkaline phosphatase.
    Jeppsson A; Wahren B; Millán JL; Stigbrand T
    Br J Cancer; 1984 Feb; 49(2):123-8. PubMed ID: 6365130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalization.
    Ullén A; Sandström P; Ahlström KR; Sundström B; Nilsson B; Arlestig L; Stigbrand T
    Cancer Res; 1995 Dec; 55(23 Suppl):5868s-5873s. PubMed ID: 7493362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.
    Pavlinkova G; Beresford GW; Booth BJ; Batra SK; Colcher D
    J Nucl Med; 1999 Sep; 40(9):1536-46. PubMed ID: 10492377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding characteristics and tumor targeting of a covalently linked divalent CC49 single-chain antibody.
    Beresford GW; Pavlinkova G; Booth BJ; Batra SK; Colcher D
    Int J Cancer; 1999 Jun; 81(6):911-7. PubMed ID: 10362138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoscintigraphy of gynecologic tumors with 131I-labeled anti-PLAP monoclonal antibodies.
    Riklund KE; Edbom G; Makiya R; Johansson B; Gerdes U; Hietala SO; Ekelund L; Stigbrand T; Stendahl U
    Acta Radiol; 1991 Sep; 32(5):375-80. PubMed ID: 1910991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv.
    Adams GP; McCartney JE; Tai MS; Oppermann H; Huston JS; Stafford WF; Bookman MA; Fand I; Houston LL; Weiner LM
    Cancer Res; 1993 Sep; 53(17):4026-34. PubMed ID: 7689421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors contributing to imaging of xenografts using anti-placental alkaline phosphatase monoclonal antibody.
    Koshida K; Yokoyama K; Uchibayashi T; Yamamoto H; Hirano K; Namiki M
    J Urol; 1997 May; 157(5):1941-5. PubMed ID: 9112568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved tumor targeting by combined use of two antitenascin antibodies.
    Petronzelli F; Pelliccia A; Anastasi AM; D'Alessio V; Albertoni C; Rosi A; Leoni B; De Angelis C; Paganelli G; Palombo G; Dani M; Carminati P; De Santis R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.